Geode Capital Management, LLC Nuvectis Pharma, Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 285,332 shares of NVCT stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

285,332

Previous 135,333 110.84%

Holding current value

$1.95 Million

Previous $1.32 Million 61.2%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$7.47 - $10.96 $1.12 Million - $1.64 Million	149,999 Added 110.84%	285,332 $2.13 Million
Q1 2025 May 13, 2025	BUY	$5.37 - $10.46 $301,203 - $586,701	56,090 Added 70.78%	135,333 $1.32 Million
Q4 2024 Feb 12, 2025	SELL	$4.52 - $10.98 $2,137 - $5,193	-473 Reduced 0.59%	79,243 $430,000
Q3 2024 Nov 12, 2024	BUY	$6.16 - $7.23 $163,172 - $191,515	26,489 Added 49.77%	79,716 $501,000
Q2 2024 Aug 09, 2024	SELL	$5.98 - $8.25 $486,179 - $670,733	-81,301 Reduced 60.43%	53,227 $336,000
Q1 2024 May 13, 2024	BUY	$6.69 - $11.0 $19,206 - $31,581	2,871 Added 2.18%	134,528 $1.1 Million
Q4 2023 Feb 13, 2024	BUY	$7.85 - $11.78 $15,652 - $23,489	1,994 Added 1.54%	131,657 $1.1 Million
Q3 2023 Nov 13, 2023	BUY	$12.89 - $16.29 $220,767 - $278,998	17,127 Added 15.22%	129,663 $1.67 Million
Q2 2023 Aug 11, 2023	BUY	$12.62 - $18.4 $978,226 - $1.43 Million	77,514 Added 221.33%	112,536 $1.8 Million
Q1 2023 May 15, 2023	BUY	$7.32 - $14.37 $26,747 - $52,507	3,654 Added 11.65%	35,022 $459,000
Q4 2022 Feb 13, 2023	SELL	$6.7 - $7.74 $489 - $565	-73 Reduced 0.23%	31,368 $235,000
Q3 2022 Nov 14, 2022	BUY	$7.09 - $13.0 $52,990 - $97,162	7,474 Added 31.18%	31,441 $222,000
Q2 2022 Aug 12, 2022	BUY	$7.02 - $20.44 $64,197 - $186,923	9,145 Added 61.7%	23,967 $268,000
Q1 2022 May 13, 2022	BUY	$3.25 - $9.1 $48,171 - $134,880	14,822 New	14,822 $109,000

Others Institutions Holding NVCT

# of Institutions

Shares Held

3.21M

Call Options Held

44.5K

Put Options Held

50.1K

View Full List

About Nuvectis Pharma, Inc.

Ticker NVCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,642,500
Market Cap $100M
Description
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...

More about NVCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Nuvectis Pharma, Inc. Transaction History